The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Tuesday, 25 September 2018
The large randomised controlled ASCEND trial (n=15,480) shows that aspirin reduced the risk of serious vascular events in people with diabetes and no CVD by 12% but also increased the risk of major bleeding by 29% and the authors concluded that absolute benefits were outweighed by bleeding hazard. The trial suggests that aspirin should not be used for primary prevention in patients with diabetes
Topics covered:
Tuesday, 25 September 2018
The recent TRANSITION study shows that sacubitril/valsartan can be initiated early and safely in a wide range of heart failure (HF) patients with reduced ejection fraction (HFrEF) who have been stabilized after hospitalization due to an acute HF episode. Patients involved in the study included those with no prior experience of sacubitril/valsartan or conventional HF therapies, as well as those with prior experience of conventional HF therapies.
Topics covered:
Tuesday, 25 September 2018
A new study supports the growing body of evidence showing that consumption of full-fat milk, yoghurt, cheese and butter does not increase heart disease, stroke or overall mortality in older adults. The study also suggested that increased levels of one fatty acid may actually lower the risk of stroke.
Topics covered:
Wednesday, 05 September 2018
This article provides a pragmatic approach for primary care following NICE’s update to their guidance on identification and management of familial hypercholesterolaemia (CG 71) published in November 2017.  
Category: Editorial
Thursday, 16 August 2018
Increased physical activity, not weight loss, gives individuals with coronary heart disease (CHD) including angina and myocardial infarction a longer lifespan, according to a new long-term Norwegian study.
Thursday, 16 August 2018
A new study shows that medicines effective in treating type 2 diabetes in adults do not slow disease progression in young people. The researchers commented that this is a disturbing finding as type 2 diabetes among young is a growing problem.
Topics covered:
Thursday, 16 August 2018
A large, multicentre randomised control trial comparing combination low-dose rivaroxaban (2.5 mg twice daily) plus aspirin (100 mg once daily) in people with stable peripheral arterial disease (PAD) or carotid artery disease (CAD) showed that combination therapy reduced the composite primary outcome of cardiovascular death, stroke or myocardial infarction and increased the risk of major bleeds compared with aspirin (100 mg once daily) alone.
Wednesday, 04 July 2018
Using a healthy lifestyle smartphone application helps to slow artery ageing, according to results from the EVIDENT II trial presented at the recent EuroHeartCare 2018 conference.
Wednesday, 04 July 2018
‘Virtual’ follow-up visits for patients with hypertension appeared to be just as effective as clinic visits in helping maintain blood pressure control. A US study found no significant difference in outcomes, including the need for specialist referrals or hospitalization, between patients checking in with their primary care physicians via a secure website to report aspects of their hypertension care and those who did so in the practice.
Wednesday, 04 July 2018
Loneliness injures the heart and is a strong predictor of premature death, according to a study presented at EuroHeartCare 2018, the European Society of Cardiology's annual nursing congress. The study found that feeling lonely was a stronger predictor of poor outcomes than living alone, in both men and women.

Article search and filter